The Society for Women’s Health Research
Announces Annual Gala,
Highlighting Innovations in Molecular Diagnostics
Nation’s Leader in Women’s Health
Brings Together Members of Congress, Academic Researchers
and Women’s Health Advocates
Washington, D.C. – The
Society for Women’s Health Research (SWHR), the leading
voice on women’s health issues and research into the
biological differences between men and women, will hold the
Annual SWHR Gala Dinner on Wednesday, April 2, at the
Ritz-Carlton Hotel in Washington, D.C. This year’s theme is
“Transforming Science: Innovations in Molecular
Diagnostics,” will mark the launch of SWHR’s public
initiatives in the exciting field of molecular diagnostics
and its powerful impact on women’s health. Find out more at
www.swhr.org
Each year, the gala attracts
more than 600 opinion leaders, policy makers and
researchers, including members of Congress and the
administration, women’s health advocates, clinicians and
researchers, professional and scientific associations, and
members of the media.
This year’s event will bring
greater attention to molecular diagnostics, which is
revolutionizing health care and personalized medicine by
helping to uncover the underlying mechanisms of disease and
enabling doctors and clinicians to customize care at an
individual level. Molecular diagnostics are tests that
detect specific genetic sequences and proteins to help make
individualized, and therefore more effective, medical
decisions for patients.
SWHR is developing a 7-minute
video highlighting the latest innovations in this
breakthrough technology on coronary artery disease, breast
cancer, ovarian cancer, colorectal cancer, sexually
transmitted diseases, and mental health. The video will be
the cornerstone of a national public education campaign
emphasizing the importance of molecular diagnostics in
better prevention, diagnosis and treatment of disease.
“For almost 25 years, the
Society for Women’s Health Research has been advocating for
understanding differences in prevention, diagnosis and
treatment of conditions that affect both women and men. The
annual SWHR gala is truly the main event for bringing
together the key decision-makers and stakeholders in women’s
health,” said Phyllis Greenberger, SWHR president and CEO.
“This year’s gala offers us the opportunity to feature one
of the most important medical advances in the last century.
Molecular diagnostics provides the critical insights that
enable early detection and appropriate treatment for each
gender.”
####
The Society
for Women’s Health Research (SWHR) is
the national thought leader in the study of biological
differences in disease, dedicated to transforming women’s
health through science, advocacy and education. SWHR
advocates for increased public and private funding for
women’s health; greater inclusion of women and minorities in
medical studies; and analysis of the biological differences
between men and women in disease and health issues. For more
information, visit
www.swhr.org |